CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to ATXS

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Dec '26
ATXSPhase 3

navenibart Phase 3 Est. Readout

navenibart
Dec 2026~
CT.gov
00%
Competitive Landscape

0 competitors in Hereditary Angioedema (HAE)

View Full Landscape
Drug Information

Target Indication

Hereditary Angioedema (HAE)

Clinical Trial

NCT06842823

Last updated: 12/4/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.